New implant aims to restore erections after prostate surgery
Disease control
Recruiting now
This study tests a new device implanted during prostate cancer surgery to treat erectile dysfunction. It involves 20 men aged 30-70 who are having nerve-sparing prostatectomy. The device is activated daily, and participants are followed for 6 months to check safety, effectiveness…
Phase: NA • Sponsor: Comphya Australia • Aim: Disease control
Last updated May 14, 2026 12:05 UTC